Determination of Posture in Patients With Restrictive and Obstructive Lung Disease
NCT ID: NCT06306482
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
90 participants
OBSERVATIONAL
2024-03-07
2026-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Capacity, Pulmonary Function and Physical Activity Level in Patients Lung Cancer Undergoing Pneumonectomy
NCT04807153
The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases.
NCT03420209
Relationship Between Hand Dynamometer Measurements, PFT, and mFI With Postoperative Outcomes
NCT06338007
Evaluation of Postural Effects on Multiple-breath-washout Derived Lung Function Parameters
NCT02826239
Core Stability and Respiratory Parameters in Children With Thoracic Hyperkyphosis
NCT06853548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Patients with chronic obstructive lung disease, asthma, cystic fibrosis and bronchiectasis.
No interventions assigned to this group
Group B
Patients with diffuse parenchymal lung diseases
No interventions assigned to this group
control group
healthy aged matched individuals.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stage 1-2-3-4 according to the GOLD,
* Being clinically stable for the last 4 weeks.
* Being diagnosed with CF as a result of two sweat tests,
* Being over 18 years old.
* Diagnosed with asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA),
* Clinically stable for the last 1 month
* Being over 18 years old.
* Being over 18 years old,
* Being diagnosed with bronchiectasis other than cystic fibrosis,
* Being clinically stable for the last 1 month.
* Being diagnosed with diffuse parenchymal lung according to American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
* Being over 18 years old,
* Having volunteered to participate in the research,
* To be clinically stable and to have comorbid conditions (such as hypertension, diabetes) under control,
Exclusion Criteria
* Having central and peripheral vestibular disease,
* Communication problems, known mental and cognitive problems,
* Having undergone any surgical intervention related to the spine within the last six months,
* Being in acute pulmonary exacerbation period,
* Receiving long-term oxygen therapy,
* Having undergone any surgical intervention related to the spine within the last six months,
* Change in medication for the last 1 month.
* Having undergone any surgical intervention related to the spine in the last six months,
* Receiving long-term oxygen therapy,
* Having undergone any surgical intervention related to the spine in the last six months.
* Having undergone any surgical intervention related to the spine within the last six months,
* Having exacerbation in the last 3 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aynur Demirel
Principal investigator; PT, PhD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aynur Demirel
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aynur Demirel
Ankara, , Turkey (Türkiye)
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBA 23/390
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.